Evidence map›Paper›PMID 37608487›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2023

Exhaled breath specimens subjected to point-of-care lipoarabinomannan testing.

F Nabeemeeah, R Sabet, T Moloantoa, Z Waja, Z Pretorius, K Majoro, M Letutu-Xaba, C Vilaplana, J Nigou, N Martinson

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

F NabeemeeahPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
R SabetPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
T MoloantoaPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Z WajaPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Z PretoriusPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
K MajoroPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
M Letutu-XabaPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
C VilaplanaExperimental Tuberculosis Unit, Microbiology Department, Institut i Hospital d'Investigació en Ciències de la Salut i Hospital Germans Trias i Pujol, Dirección Clínica Territorial de Malalties Infeccioses i Salut Internacional de Gerència Territorial Metropolitana Nord, Badalona, Catalonia, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain.
J NigouInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Centre national de la recherche scientifique, Université Toulouse III - Paul Sabatier, Toulouse, France.
N MartinsonPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa, Johns Hopkins University Centre for TB Research, Baltimore, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ExhalationPoint-of-Care SystemsHumansLipopolysaccharideslipoarabinomannanLipopolysaccharides

Identifiers

PMID37608487
PMCPMC10443782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.